SAHZU Colorectal Surgeons to Improve Medical Communication Between Chinese and Italian Surgeons
From May 27 to May 31, Prof. DING Kefeng, Vice Chairman of Colorectal Cancer Committee of the Chinese Anti-Cancer Association and Vice Presi...
From May 27 to May 31, Prof. DING Kefeng, Vice Chairman of Colorectal Cancer Committee of the Chinese Anti-Cancer Association and Vice Presi...
Some gut bacteria can collaborate to promote T-cell action against tumours in mice, raising hopes for treatments.A new study led by Zhejiang...
Chief Executive Officer of Singapore National Eye Centre (SNEC) Prof. AUNG Tin visited SAHZU Eye Center on May 15. During the visit, SAHZU, ...
Early-stage oral tongue squamous cell carcinoma (OTSCC) comprises 25‒40% of oral cancer, and has relatively poorer survival outcomes compare...
ZHANG Guojie, Chair Professor and director of the Centre for Evolutionary and Organismal Biology at Zhejiang University, has been elected as...
“It's wonderful that my daughter doesn't need dialysis anymore. Her skin is lightened and she becomes more outgoing. Thank you so m...
On April 18, 2024, two esteemed orthopedic surgeons from Bangkok, Thailand, embarked on a two-day visit to the First Affiliated Hospital, Zh...
Bone is one of the most common sites of early metastasis of cancer and is also a hotbed for tumor cells. Why do tumor cells go after hard bo...
Bipolar disorder is a severe and disabling psychiatric disorderwith the potentialfor adverse outcomes, such as suicide, if patient...
Dr. CAO Hongcui, a professor at the First Affiliated Hospital of Zhejiang University School of Medicine (FAHZU), was honored with the presti...
A few days ago, Bei Bei's parents took Bei Bei to the Genetics and Metabolism Department of the Children's Hospital of Zhejiang Univ...
GU Chenhui, a second-year doctoral student from the School of Medicine, focuses on basic research and technological transformation of natura...
In a significant stride for China's presence on the global stage of cell immunotherapy, Professor HUANG He from the Bone Marro...
Chimeric Antigen Receptor T-cell (CAR-T) therapy, a pioneering treatment for B-cell malignancies, has garnered significant attention lately ...